Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Radar Therapeutics logo — Programming genetic medicines for exquisite specificity

Radar Therapeutics

Programming genetic medicines for exquisite specificity

16 employees Seed Total: $13.40M Health and Wellness

General Information

Company Name Radar Therapeutics
Employees 16
Industries Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Radar Therapeutics. To contact Radar Therapeutics, visit radartx.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Radar Therapeutics

Radar Therapeutics is a Health and Wellness startup that aims to pave the way for advanced treatment through pioneering precision-expressed mRNA-based therapeutics. The company recently received a significant boost with a $13.40M Seed Round investment on 23 May 2024, attracting the attention of high-profile investors including Pear Ventures, KdT Ventures, Biovision Ventures, Eli Lilly, BEVC, Mei Z., and NFX Bio. This substantial investment marks an important milestone for Radar Therapeutics, positioning the company for further growth and development in the cutting-edge field of precision medicine. With this recent injection of funds, Radar Therapeutics is poised to make significant strides in revolutionizing mRNA-based therapeutics and making a meaningful impact in the healthcare industry.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $13.40M 7
Pear Ventures KdT Ventures Biovision Ventures
Pear Ventures, KdT Ventures +5
23 May 2024
Grant Undisclosed 1
Pear Competition
09 May 2023

Radar Therapeutics Alternatives & Competitors

Radar Therapeutics vs
GenEdit
GenEdit United States

Delivering the potential of genetic medicines

Series A
47 employees
Biotechnology, Health and Wellness
Radar Therapeutics vs
NanoVation Therapeutics™
NanoVation Therapeutics™ Canada

Delivering tomorrow's genetic medicines, today™

Grant
42 employees
Biotechnology, Health and Wellness
Radar Therapeutics vs
Cognigenics
Cognigenics United States

Shaping the Future of Genetic Medicines for Mental Health and Neurocognitive Disorders

Seed
20 employees
Health and Wellness

FAQ About Radar Therapeutics

Programming genetic medicines for exquisite specificity
Radar Therapeutics operates in Health and Wellness.
Radar Therapeutics has approximately 16 employees.
Radar Therapeutics has completed 2 funding rounds, raising a total of $13.40M. The latest funding stage is Seed.
Top alternatives and competitors to Radar Therapeutics include GenEdit, NanoVation Therapeutics™, Cognigenics, Nuntius Therapeutics, Maze Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Radar Therapeutics and GenEdit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Radar Therapeutics, https://bouncewatch.com/company/radar-therapeutics, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes